Peter has over 30 years’ experience in the pharmaceutical arena where he has worked within Contract Research Organisations Inveresk, Quintiles and Aptuit as Director of DMPK. For the last 10 years he has been an independent consultant working on all aspects of non-clinical drug development including metabolism, pharmacokinetics, bioanalysis and toxicology. He also has extensive experience of the preparation of non-clinical documentation for all aspects of clinical Phase I – III studies. He has worked with Antabio since 2018 and is currently Head of Safety and DMPK.
